只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-30 2026-07-31 | IONS IONIS PHARMACEUTICALS INC | Hayden Michael R Director | 买入（P） | 15,000 | US$53.38 | US$800,700.00 | 19,000 | SEC |
| 2026-07-30 2026-07-31 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 644 | US$523.04 | US$336,836.54 | 333,299 | SEC |
| 2026-07-30 2026-07-31 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,486 | US$523.87 | US$778,478.10 | 331,813 | SEC |
| 2026-07-30 2026-07-31 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 4,846 | US$524.88 | US$254.36万 | 326,967 | SEC |
| 2026-07-30 2026-07-31 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,084 | US$525.80 | US$109.58万 | 324,883 | SEC |
| 2026-07-30 2026-07-31 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 400 | US$526.92 | US$210,769.20 | 324,483 | SEC |
| 2026-07-30 2026-07-31 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 40 | US$528.96 | US$21,158.40 | 324,443 | SEC |
| 2026-07-30 2026-07-31 | ADP AUTOMATIC DATA PROCESSING INC | Kwon David Officer · Corp VP | 卖出（S） | 474 | US$265.62 | US$125,903.88 | 11,599.553 | SEC |
| 2026-07-30 2026-07-31 | ADP AUTOMATIC DATA PROCESSING INC | Kwon David Officer · Corp VP | 卖出（S） | 887 | US$265.62 | US$235,604.94 | 10,712.553 | SEC |
| 2026-07-30 2026-07-31 | ADP AUTOMATIC DATA PROCESSING INC | Kwon David Officer · Corp VP | 卖出（S） | 1,053 | US$265.62 | US$279,697.86 | 9,659.553 | SEC |
| 2026-07-30 2026-07-31 | NTIC NORTHERN TECHNOLOGIES INTERNATIONAL CORP | LYNCH G PATRICK Director,Officer,TenPercentOwner · President and CEO | 卖出（S） | 16,070 | US$8.00 | US$128,506.97 | 105,284 | SEC |
| 2026-07-30 2026-07-31 | TPL Texas Pacific Land Corp | HORIZON KINETICS ASSET MANAGEMENT LLC TenPercentOwner | 买入（P） | 1 | US$389.14 | US$389.14 | 3,263,687 | SEC |
| 2026-07-30 2026-07-31 | RCG RENN Fund, Inc. | HORIZON KINETICS ASSET MANAGEMENT LLC TenPercentOwner | 买入（P） | 756 | US$3.06 | US$2,313.36 | 944,004 | SEC |
| 2026-07-30 2026-07-31 | ACAD ACADIA PHARMACEUTICALS INC | Thompson Elizabeth H.Z. Officer · EVP, Head of Research & Dev | 卖出（S） | 16,508 | US$26.13 | US$431,354.04 | 19,044 | SEC |
| 2026-07-30 2026-07-31 | ACAD ACADIA PHARMACEUTICALS INC | Thompson Elizabeth H.Z. Officer · EVP, Head of Research & Dev | 卖出（S） | 50 | US$26.17 | US$1,308.50 | 18,994 | SEC |
| 2026-07-30 2026-07-30 | CYTK CYTOKINETICS INC | Callos Andrew Officer · EVP, Chief Commercial Officer | 卖出（S） | 14,000 | US$79.88 | US$111.83万 | 58,555 | SEC |
| 2026-07-30 2026-07-30 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn Officer · Chief Scientific Officer | 卖出（S） | 3,847 | US$23.38 | US$89,953.63 | 121,338 | SEC |
| 2026-07-30 2026-07-30 | NRIX Nurix Therapeutics, Inc. | Ring Christine Officer · Chief Legal Officer | 卖出（S） | 3,847 | US$23.38 | US$89,953.63 | 19,912 | SEC |
| 2026-07-30 2026-07-30 | NRIX Nurix Therapeutics, Inc. | van Houte Hans Officer · Chief Financial Officer | 卖出（S） | 2,845 | US$23.38 | US$66,524.07 | 44,927 | SEC |
| 2026-07-30 2026-07-30 | MLPT MapLight Therapeutics, Inc. | Catalyst4, Inc. TenPercentOwner | 买入（P） | 1,000,000 | US$13.00 | US$1300万 | 20,906,689 | SEC |
| 2026-07-29 2026-07-31 | VRSK Verisk Analytics, Inc. | Shavel Lee Director,Officer · Chief Executive Officer | 卖出（S） | 2,500 | US$220.00 | US$550,000.00 | 98,490 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | NTIC NORTHERN TECHNOLOGIES INTERNATIONAL CORP | LYNCH G PATRICK Director,Officer,TenPercentOwner · President and CEO | 卖出（S） | 2 | US$8.10 | US$16.20 | 121,354 | SEC |
| 2026-07-29 2026-07-31 | KNSA Kiniksa Pharmaceuticals International, plc | Cole G Bradley Director | 卖出（S） | 3,673 | US$81.43 | US$299,092.39 | 11,672 | SEC |
| 2026-07-29 2026-07-31 | MAZE Maze Therapeutics, Inc. | Dandekar Atul Officer · CSBO | 卖出（S） | 7,100 | US$27.31 | US$193,875.44 | 26,650 | SEC |
| 2026-07-29 2026-07-31 | MAZE Maze Therapeutics, Inc. | Dandekar Atul Officer · CSBO | 卖出（S） | 400 | US$27.89 | US$11,156.00 | 26,250 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 798 | US$518.25 | US$413,564.62 | 333,145 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,112 | US$519.29 | US$577,453.15 | 332,033 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 900 | US$520.40 | US$468,363.78 | 331,133 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,270 | US$521.32 | US$662,077.80 | 329,863 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 880 | US$522.51 | US$459,813.11 | 328,983 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,318 | US$523.63 | US$690,137.75 | 327,665 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,982 | US$524.47 | US$103.95万 | 325,683 | SEC |
| 2026-07-29 2026-07-30 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,240 | US$525.46 | US$651,574.86 | 324,443 | SEC |
| 2026-07-29 2026-07-30 | TPL Texas Pacific Land Corp | HORIZON KINETICS ASSET MANAGEMENT LLC TenPercentOwner | 买入（P） | 1 | US$394.14 | US$394.14 | 3,263,686 | SEC |
| 2026-07-29 2026-07-30 | RCG RENN Fund, Inc. | HORIZON KINETICS ASSET MANAGEMENT LLC TenPercentOwner | 买入（P） | 756 | US$3.04 | US$2,298.24 | 943,248 | SEC |
| 2026-07-29 2026-07-30 | ANIP ANI PHARMACEUTICALS INC | CAREY STEPHEN P. Officer · SVP & CFO | 卖出（S） | 2,850 | US$81.36 | US$231,876.00 | 174,693 | SEC |
| 2026-07-29 2026-07-30 | MLPT MapLight Therapeutics, Inc. | Catalyst4, Inc. TenPercentOwner | 买入（P） | 3,000 | US$12.63 | US$37,890.00 | 19,906,689 | SEC |
| 2026-07-29 2026-07-29 | VKTX Viking Therapeutics, Inc. | Mancini Marianna Officer · Chief Operating Officer | 卖出（S） | 18,217 | US$33.47 | US$609,635.55 | 422,760 | SEC |
| 2026-07-29 2026-07-29 | VKTX Viking Therapeutics, Inc. | ZANTE GREG Officer · Chief Financial Officer | 卖出（S） | 21,217 | US$33.47 | US$710,141.48 | 212,204 | SEC |
| 2026-07-29 2026-07-29 | VKTX Viking Therapeutics, Inc. | Lian Brian Director,Officer · President & CEO | 卖出（S） | 148,517 | US$33.32 | US$494.79万 | 2,572,441 | SEC |
| 2026-07-29 2026-07-29 | OTLK Outlook Therapeutics, Inc. | Sukhtian Faisal Ghiath Director | 买入（P） | 95,398 | US$1.05 | US$99,996.18 | 220,972 | SEC |
| 2026-07-28 2026-07-30 | RLAY Relay Therapeutics, Inc. | Bergstrom Donald A Officer · President, R&D | 卖出（S） | 2,237 | US$18.61 | US$41,630.57 | 407,660 | SEC |
| 2026-07-28 2026-07-30 | RLAY Relay Therapeutics, Inc. | Rahmer Peter Officer · See remarks | 卖出（S） | 748 | US$18.61 | US$13,920.28 | 228,165 | SEC |
| 2026-07-28 2026-07-30 | RLAY Relay Therapeutics, Inc. | Catinazzo Thomas Officer · Chief Financial Officer | 卖出（S） | 1,459 | US$18.61 | US$27,151.99 | 158,285 | SEC |
| 2026-07-28 2026-07-30 | KPTI Karyopharm Therapeutics Inc. | Poulton Stuart Officer · EVP, Chief Development Officer | 卖出（S） | 189 | US$7.10 | US$1,341.90 | 94,632 | SEC |
| 2026-07-28 2026-07-30 | MLPT MapLight Therapeutics, Inc. | Catalyst4, Inc. TenPercentOwner | 买入（P） | 141,088 | US$10.74 | US$151.55万 | 19,838,552 | SEC |
| 2026-07-28 2026-07-30 | MLPT MapLight Therapeutics, Inc. | Catalyst4, Inc. TenPercentOwner | 买入（P） | 65,137 | US$11.69 | US$761,392.91 | 19,903,689 | SEC |
| 2026-07-28 2026-07-29 | DGX QUEST DIAGNOSTICS INC | DELANEY MARK E Officer · SVP & Chief Commercial Officer | 卖出（S） | 1,600 | US$235.18 | US$376,288.00 | 10,335 | SEC |
| 2026-07-28 2026-07-29 | TPL Texas Pacific Land Corp | HORIZON KINETICS ASSET MANAGEMENT LLC TenPercentOwner | 买入（P） | 1 | US$393.09 | US$393.09 | 3,263,685 | SEC |
| 2026-07-28 2026-07-29 | RCG RENN Fund, Inc. | HORIZON KINETICS ASSET MANAGEMENT LLC TenPercentOwner | 买入（P） | 756 | US$3.05 | US$2,305.80 | 942,492 | SEC |
| 2026-07-28 2026-07-29 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 1,204 | US$254.07 | US$305,900.88 | 132,429 | SEC |
| 2026-07-28 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Aghazadeh Behzad Director,TenPercentOwner,Other | 买入（P） | 7,905 | US$18.25 | US$144,266.25 | 3,088,888 | SEC |
| 2026-07-28 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Avoro Capital Advisors LLC Director,TenPercentOwner,Other | 买入（P） | 7,905 | US$18.25 | US$144,266.25 | 3,088,888 | SEC |
| 2026-07-28 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Avoro Ventures LLC Director,Other | 买入（P） | 7,905 | US$18.25 | US$144,266.25 | 3,088,888 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,367 | US$523.15 | US$715,152.06 | 332,576 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 40 | US$532.49 | US$21,299.58 | 324,443 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,074 | US$524.04 | US$562,817.56 | 331,502 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 876 | US$525.02 | US$459,918.05 | 330,626 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,473 | US$526.34 | US$775,294.70 | 329,153 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,369 | US$527.16 | US$721,677.66 | 327,784 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,149 | US$528.20 | US$606,904.56 | 326,635 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 625 | US$529.41 | US$330,882.38 | 326,010 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,124 | US$530.29 | US$596,047.98 | 324,886 | SEC |
| 2026-07-28 2026-07-28 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 403 | US$530.97 | US$213,981.03 | 324,483 | SEC |
| 2026-07-28 2026-07-28 | MPLT MapLight Therapeutics, Inc. | Cox Troy Director | 买入（P） | 15,620 | US$9.52 | US$148,702.40 | 15,620 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | ORBIMED ADVISORS LLC Director | 买入（P） | 1,000,000 | US$15.00 | US$1500万 | 1,348,825 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | OrbiMed Capital GP VIII LLC Director | 买入（P） | 1,000,000 | US$15.00 | US$1500万 | 1,348,825 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | GORDON CARL L Director | 买入（P） | 1,000,000 | US$15.00 | US$1500万 | 1,348,825 | SEC |
| 2026-07-27 2026-07-29 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham Director,Officer · Chief Executive Officer | 卖出（S） | 2,203 | US$42.11 | US$92,761.72 | 537,614 | SEC |
| 2026-07-27 2026-07-29 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham Director,Officer · Chief Executive Officer | 卖出（S） | 7 | US$42.74 | US$299.15 | 537,607 | SEC |
| 2026-07-27 2026-07-29 | BEAM Beam Therapeutics Inc. | Simon Amy Officer · Chief Medical Officer | 卖出（S） | 16,667 | US$25.74 | US$429,036.91 | 85,696 | SEC |
| 2026-07-27 2026-07-29 | DYN Dyne Therapeutics, Inc. | Kersten Dirk Director | 卖出（S） | 256,072 | US$25.50 | US$653.05万 | 3,592,184 | SEC |
| 2026-07-27 2026-07-29 | DYN Dyne Therapeutics, Inc. | Kersten Dirk Director | 卖出（S） | 5,388 | US$26.04 | US$140,318.61 | 3,586,796 | SEC |
| 2026-07-27 2026-07-29 | MLTX MoonLake Immunotherapeutics | Reich Kristian Officer · Chief Scientific Officer | 卖出（S） | 1,100 | US$20.00 | US$22,000.00 | 2,711,198 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | AH Bio Fund II, L.P. TenPercentOwner | 买入（P） | 333,333 | US$15.00 | US$500万 | 2,385,075 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | AH Equity Partners Bio II, L.L.C. TenPercentOwner | 买入（P） | 333,333 | US$15.00 | US$500万 | 2,385,075 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | AH Bio Fund III, L.P. TenPercentOwner | 买入（P） | 333,333 | US$15.00 | US$500万 | 2,385,075 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | AH Equity Partners Bio III, L.L.C. TenPercentOwner | 买入（P） | 333,333 | US$15.00 | US$500万 | 2,385,075 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | Andreessen Marc L TenPercentOwner | 买入（P） | 333,333 | US$15.00 | US$500万 | 2,385,075 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | HOROWITZ BENJAMIN A TenPercentOwner | 买入（P） | 333,333 | US$15.00 | US$500万 | 2,385,075 | SEC |
| 2026-07-27 2026-07-29 | AVTX Avalo Therapeutics, Inc. | Doyle Mittie Officer · Chief Medical Officer | 卖出（S） | 1,000 | US$20.00 | US$20,000.00 | 51,776 | SEC |
| 2026-07-27 2026-07-29 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 1,010 | US$260.49 | US$263,095.71 | 133,633 | SEC |
| 2026-07-27 2026-07-28 | RCG RENN Fund, Inc. | HORIZON KINETICS ASSET MANAGEMENT LLC TenPercentOwner | 买入（P） | 756 | US$3.03 | US$2,290.68 | 941,736 | SEC |
| 2026-07-27 2026-07-28 | TPL Texas Pacific Land Corp | HORIZON KINETICS ASSET MANAGEMENT LLC TenPercentOwner | 买入（P） | 1 | US$409.31 | US$409.31 | 3,263,684 | SEC |
| 2026-07-27 2026-07-28 | SOPH SOPHiA GENETICS SA | Menu Philippe Officer · Chief Medical Officer | 卖出（S） | 5,000 | US$5.66 | US$28,305.50 | 223,387 | SEC |
| 2026-07-27 2026-07-28 | SYNA SYNAPTICS Inc | Gupta Vikram Officer · See Remarks | 卖出（S） | 360 | US$114.20 | US$41,112.00 | 81,226 | SEC |
| 2026-07-27 2026-07-27 | CYTK CYTOKINETICS INC | Blum Robert I Director,Officer · President & CEO | 卖出（S） | 7,500 | US$80.87 | US$606,525.00 | 377,820 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 680 | US$525.81 | US$357,551.55 | 333,263 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 890 | US$527.14 | US$469,152.46 | 332,373 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 650 | US$528.51 | US$343,529.55 | 331,723 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,797 | US$529.75 | US$951,959.49 | 329,926 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,121 | US$530.49 | US$594,674.92 | 328,805 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,836 | US$531.65 | US$976,107.20 | 326,969 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,529 | US$532.38 | US$814,004.43 | 325,440 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 957 | US$533.53 | US$510,589.55 | 324,483 | SEC |
| 2026-07-27 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 40 | US$535.04 | US$21,401.60 | 324,443 | SEC |
| 2026-07-27 2026-07-27 | SYM Symbotic Inc. | Boyd William M III Officer · Chief Strategy Officer | 卖出（S） | 5,700 | US$40.79 | US$232,499.01 | 60,606 | SEC |
| 2026-07-27 2026-07-27 | SYM Symbotic Inc. | Boyd William M III Officer · Chief Strategy Officer | 卖出（S） | 3,494 | US$41.46 | US$144,861.94 | 57,112 | SEC |
| 2026-07-24 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Aghazadeh Behzad Director,TenPercentOwner,Other | 买入（P） | 2,333,333 | US$15.00 | US$3500万 | 3,030,983 | SEC |
| 2026-07-24 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Avoro Capital Advisors LLC Director,TenPercentOwner,Other | 买入（P） | 2,333,333 | US$15.00 | US$3500万 | 3,030,983 | SEC |
| 2026-07-24 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Avoro Ventures LLC Director,Other | 买入（P） | 2,333,333 | US$15.00 | US$3500万 | 3,030,983 | SEC |
| 2026-07-24 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Aghazadeh Behzad Director,TenPercentOwner,Other | 买入（P） | 50,000 | US$22.31 | US$111.55万 | 3,080,983 | SEC |
| 2026-07-24 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Avoro Capital Advisors LLC Director,TenPercentOwner,Other | 买入（P） | 50,000 | US$22.31 | US$111.55万 | 3,080,983 | SEC |
| 2026-07-24 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Avoro Ventures LLC Director,Other | 买入（P） | 50,000 | US$22.31 | US$111.55万 | 3,080,983 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ORIC Oric Pharmaceuticals, Inc. | Heyman Richard A. Director | 卖出（S） | 7,000 | US$12.02 | US$84,140.00 | 38,300 | SEC |
| 2026-07-24 2026-07-28 | ORIC Oric Pharmaceuticals, Inc. | Heyman Richard A. Director | 卖出（S） | 6,100 | US$12.02 | US$73,322.00 | 206,672 | SEC |
| 2026-07-24 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 820 | US$528.72 | US$433,548.76 | 333,123 | SEC |
| 2026-07-24 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,285 | US$530.45 | US$121.21万 | 330,838 | SEC |
| 2026-07-24 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,115 | US$531.10 | US$592,178.84 | 329,723 | SEC |
| 2026-07-24 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,719 | US$532.27 | US$144.72万 | 327,004 | SEC |
| 2026-07-24 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,818 | US$533.20 | US$969,355.96 | 325,186 | SEC |
| 2026-07-24 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 630 | US$534.39 | US$336,668.09 | 324,556 | SEC |
| 2026-07-24 2026-07-27 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 113 | US$535.03 | US$60,457.89 | 324,443 | SEC |
| 2026-07-24 2026-07-27 | TPL Texas Pacific Land Corp | HORIZON KINETICS ASSET MANAGEMENT LLC TenPercentOwner | 买入（P） | 1 | US$423.94 | US$423.94 | 3,263,683 | SEC |
| 2026-07-24 2026-07-27 | RCG RENN Fund, Inc. | HORIZON KINETICS ASSET MANAGEMENT LLC TenPercentOwner | 买入（P） | 756 | US$3.02 | US$2,283.12 | 940,980 | SEC |
| 2026-07-24 2026-07-27 | SYM Symbotic Inc. | Alexander Brian Daniel Officer · SVP, Commercial | 卖出（S） | 9,130 | US$40.30 | US$367,953.61 | 55,611 | SEC |
| 2026-07-24 2026-07-27 | SYM Symbotic Inc. | Freve Maria G Officer · See Remarks | 卖出（S） | 2,244 | US$40.28 | US$90,394.15 | 3,096 | SEC |
| 2026-07-24 2026-07-27 | OLMA Olema Pharmaceuticals, Inc. | Harmon Cyrus Director | 卖出（S） | 12,500 | US$11.71 | US$146,425.00 | 702,770 | SEC |
| 2026-07-24 2026-07-27 | SYM Symbotic Inc. | Kuffner James Officer · Chief Technology Officer | 卖出（S） | 18,987 | US$40.38 | US$766,695.06 | 214,062 | SEC |
| 2026-07-23 2026-07-27 | IRD Opus Genetics, Inc. | Gagnon Robert E. Officer · Chief Financial Officer | 卖出（S） | 7,783 | US$2.95 | US$22,941.95 | 584,375 | SEC |
| 2026-07-23 2026-07-27 | IRD Opus Genetics, Inc. | Magrath George Director,Officer · Chief Executive Officer | 卖出（S） | 9,475 | US$2.95 | US$27,925.67 | 1,731,869 | SEC |
| 2026-07-23 2026-07-27 | IRD Opus Genetics, Inc. | SCHACHLE JOSEPH K Officer · Chief Operating Officer | 卖出（S） | 4,644 | US$2.94 | US$13,653.36 | 291,440 | SEC |
| 2026-07-23 2026-07-27 | IRD Opus Genetics, Inc. | YERXA BENJAMIN R Director,Officer · President | 卖出（S） | 7,429 | US$2.97 | US$22,064.13 | 704,106 | SEC |
| 2026-07-23 2026-07-27 | SCTX Scribe Therapeutics, Inc. | Lucas Svetlana Officer · Chief Business Officer | 买入（P） | 3,000 | US$15.00 | US$45,000.00 | 3,000 | SEC |
| 2026-07-23 2026-07-27 | OLMA Olema Pharmaceuticals, Inc. | Harmon Cyrus Director | 卖出（S） | 12,500 | US$11.58 | US$144,737.50 | 715,270 | SEC |
| 2026-07-23 2026-07-27 | PUBM PubMatic, Inc. | Goel Rajeev K. Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 49,979 | US$12.35 | US$617,005.75 | 31,692 | SEC |
| 2026-07-23 2026-07-27 | SCTX Scribe Therapeutics, Inc. | Parrot David Officer · Chief Financial Officer | 买入（P） | 1,333 | US$15.00 | US$19,995.00 | 1,333 | SEC |
| 2026-07-23 2026-07-27 | SCTX Scribe Therapeutics, Inc. | Parrot David Officer · Chief Financial Officer | 买入（P） | 1,333 | US$15.00 | US$19,995.00 | 1,333 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 249 | US$522.87 | US$130,194.85 | 333,694 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 200 | US$531.83 | US$106,366.80 | 324,443 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 339 | US$523.72 | US$177,539.72 | 333,355 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 171 | US$524.86 | US$89,751.18 | 333,184 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 387 | US$525.83 | US$203,496.79 | 332,797 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 552 | US$526.88 | US$290,835.39 | 332,245 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,989 | US$527.77 | US$104.97万 | 330,256 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,133 | US$529.08 | US$112.85万 | 328,123 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,279 | US$529.86 | US$120.75万 | 325,844 | SEC |
| 2026-07-23 2026-07-24 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,201 | US$530.84 | US$637,540.16 | 324,643 | SEC |
| 2026-07-23 2026-07-24 | TPL Texas Pacific Land Corp | HORIZON KINETICS ASSET MANAGEMENT LLC TenPercentOwner | 买入（P） | 1 | US$429.51 | US$429.51 | 3,263,682 | SEC |
| 2026-07-23 2026-07-24 | RCG RENN Fund, Inc. | HORIZON KINETICS ASSET MANAGEMENT LLC TenPercentOwner | 买入（P） | 756 | US$3.06 | US$2,313.36 | 940,224 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-22 2026-07-24 | NTLA Intellia Therapeutics, Inc. | Dulac Edward J III Officer · EVP, Chief Financial Officer | 卖出（S） | 8,111 | US$11.25 | US$91,248.75 | 148,175 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 120 | US$524.27 | US$62,912.40 | 333,823 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 107 | US$535.40 | US$57,288.07 | 326,563 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 790 | US$536.49 | US$423,826.63 | 325,773 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 570 | US$537.60 | US$306,433.94 | 325,203 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 680 | US$538.46 | US$366,153.00 | 324,523 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 80 | US$539.47 | US$43,157.60 | 324,443 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 485 | US$526.04 | US$255,130.95 | 333,338 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 2,610 | US$526.84 | US$137.51万 | 330,728 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 1,211 | US$527.82 | US$639,188.81 | 329,517 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 874 | US$528.91 | US$462,264.89 | 328,643 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 760 | US$529.80 | US$402,644.50 | 327,883 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 400 | US$531.22 | US$212,489.80 | 327,483 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 489 | US$533.24 | US$260,755.53 | 326,994 | SEC |
| 2026-07-22 2026-07-23 | UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Director,Officer · Chairperson & CEO | 卖出（S） | 324 | US$534.19 | US$173,075.94 | 326,670 | SEC |
| 2026-07-22 2026-07-23 | MLTX MoonLake Immunotherapeutics | Reich Kristian Officer · Chief Scientific Officer | 卖出（S） | 2,448 | US$20.00 | US$48,960.00 | 2,712,298 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | RCG RENN Fund, Inc. | HORIZON KINETICS ASSET MANAGEMENT LLC TenPercentOwner | 买入（P） | 756 | US$3.06 | US$2,313.36 | 939,468 | SEC |
| 2026-07-22 2026-07-23 | TPL Texas Pacific Land Corp | HORIZON KINETICS ASSET MANAGEMENT LLC TenPercentOwner | 买入（P） | 1 | US$427.42 | US$427.42 | 3,263,681 | SEC |
| 2026-07-21 2026-07-23 | ACRV Acrivon Therapeutics, Inc. | Miller Mary Officer · Chief Legal Officer | 卖出（S） | 573 | US$1.76 | US$1,008.48 | 82,194 | SEC |
| 2026-07-21 2026-07-23 | RANI Rani Therapeutics Holdings, Inc. | IMRAN MIR A Director,TenPercentOwner | 买入（P） | 36,000 | US$0.69 | US$24,840.00 | 2,119,334 | SEC |
| 2026-07-21 2026-07-23 | CYTK CYTOKINETICS INC | Malik Fady Ibraham Officer · EVP Research & Development | 卖出（S） | 3,500 | US$80.59 | US$282,065.00 | 153,902 | SEC |
| 2026-07-21 2026-07-23 | MLTX MoonLake Immunotherapeutics | Reich Kristian Officer · Chief Scientific Officer | 卖出（S） | 50,000 | US$20.02 | US$100.1万 | 2,714,746 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| ITIC | 5,929.0664 | 0 | 7,285.1765 | 81.39% | Q, N |
| TIC | 187,709.644 | 0 | 310,255.6329 | 60.50% | B, Q, N |
| NTIC | 195 | 0 | 441.1021 | 44.21% | Q |